Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach. (2023)
Attributed to:
Materials exploitation of the biointerface to control MSC quality and niche phenotype
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12964-023-01363-2
PubMed Identifier: 38031192
Publication URI: http://europepmc.org/abstract/MED/38031192
Type: Journal Article/Review
Volume: 21
Parent Publication: Cell communication and signaling : CCS
Issue: 1
ISSN: 1478-811X